Delos Capital

Activity in this selectiontaiho-ventures-5087b202

By stage

Seed1

Series A1

Undisclosed1

Biotech2

Healthtech1

United States3

3 in this selection

Jun 16

Develops a hydrogel system to treat uterine health conditions and prevent scarring

$25MSeries A

Role not disclosed

Jan 27

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosed

Role not disclosed

Jan 7

Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy

$8MSeed2

Role not disclosed